CDER Conversation: Information Visualization Platform (InfoViP) - US Food and Drug Administration

Retrieved on: 2022-06-28 20:41:24

Tags for this article:

Food and Drug Administration

Health

Clinical research

Clinical pharmacology

Pharmaceutical industry

FDA Adverse Event Reporting System

Pharmaceuticals policy

Center for Drug Evaluation and Research

Click the tags to see associated articles and topics

CDER Conversation: Information Visualization Platform (InfoViP) - US Food and Drug Administration. View article details on HISWAI: https://www.fda.gov/drugs/news-events-human-drugs/cder-conversation-information-visualization-platform-infovip-cders-new-artificial-intelligence

Excerpt

InfoViP incorporates artificial intelligence (AI) and advanced visualizations to support OSE safety reviewer's examination of data or content to ...

Article found on: www.fda.gov

View Original Article